Hawaiian Eye/Retina Meeting

Hawaiian Eye/Retina Meeting

Source:

Goldberg JL. Pressure-independent considerations in progressive glaucoma. Presented at: Hawaiian Eye 2022; Jan. 15-21, 2022; Waikoloa, Hawaii.

Disclosures: Goldberg reports having an employee or executive role with Emmetrope Ophthalmics and consulting for Aerie, Annexon, Equinox, IrisVision, Novartis, ONL, Regeneron, ReNetX, Roche, Santen and Zeiss.
January 20, 2022
1 min read
Save

Concomitant disease should be considered when treating progressive glaucoma

Source:

Goldberg JL. Pressure-independent considerations in progressive glaucoma. Presented at: Hawaiian Eye 2022; Jan. 15-21, 2022; Waikoloa, Hawaii.

Disclosures: Goldberg reports having an employee or executive role with Emmetrope Ophthalmics and consulting for Aerie, Annexon, Equinox, IrisVision, Novartis, ONL, Regeneron, ReNetX, Roche, Santen and Zeiss.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WAIKOLOA, Hawaii — Ophthalmologists should consider co-management of other diseases when treating progressive glaucoma, according to a speaker here.

Jeffrey L. Goldberg

“I think that we need to remind ourselves, even as we rush through clinic, to think about the linkage to common disease that puts the optic nerve at risk,” Jeffrey L. Goldberg, MD, PhD, said at Hawaiian Eye 2022.

To aid with co-management, he said, physicians should ensure the patient’s hypertension is under control, have patients avoid hypotensive medications at bedtime and encourage the use of a continuous positive airway pressure machine in patients with obstructive sleep apnea. Patients should also be treated for inflammatory disorders, and metabolic and nutritional status should be optimized. In young patients with unilateral glaucoma, MRI and neuroimaging should be considered.

Goldberg said ophthalmologists should work with the patient’s other doctors to help manage their concomitant diseases.

“Let’s welcome a future where we test for and treat these pathologies, and I think we have a number of different candidate therapies coming down the road in that direction right now,” he said.